Afficher la couverture 'KBTBD13 is an actin-binding protein that modulates muscle kinetics | de Winter, Josine Marieke' en grand format
/5

0 avis

KBTBD13 is an actin-binding protein that modulates muscle kinetics

Archive ouverte

de Winter, Josine Marieke | Molenaar, Joery P.F. | Yuen, Michaela | van Der Pijl, Robbert J. | Shen, Shengyi | Conijn, Stefan | van de Locht, Martijn | Willigenburg, Menne | Bogaards, Sylvia J.P. | van Kleef, Esmee S.B. | Lassche, Saskia | Persson, Malin | Rassier, Dilson E. | Sztal, Tamar E. | Ruparelia, Avnika Ashok | Oorschot, Viola M.J. | Ramm, Georg | Hall, Thomas E. | Xiong, Zherui | Johnson, Christopher N. | Li, Frank W. | Kiss, Balázs | Lozano-Vidal, Noelia | Boon, Reinier A. | Marabita, Manuela | Nogara, Leonardo | Blaauw, Bert | Rodenburg, Richard J.T. | Küsters, Benno | Doorduin, Jonne | Beggs, Alan H. | Granzier, Henk L.M. | Campbell, Kenneth S. | Ma, Weikang | Irving, Thomas C. | Malfatti, Eduardo | Romero, Norma Beatriz | Bryson-Richardson, Robert J. | van Engelen, Baziel G.M. | Voermans, Nicol C. | Ottenheijm, Coen A.C.

Edité par CCSD ; American Society for Clinical Investigation -

International audience. The mechanisms that modulate the kinetics of muscle relaxation are critically important for muscle function. A prime example of the impact of impaired relaxation kinetics is nemaline myopathy caused by mutations in KBTBD13 (NEM6). In addition to weakness, NEM6 patients have slow muscle relaxation, compromising contractility and daily life activities. The role of KBTBD13 in muscle is unknown, and the pathomechanism underlying NEM6 is undetermined. A combination of transcranial magnetic stimulation-induced muscle relaxation, muscle fiber- and sarcomere-contractility assays, low-angle x-ray diffraction, and superresolution microscopy revealed that the impaired muscle-relaxation kinetics in NEM6 patients are caused by structural changes in the thin filament, a sarcomeric microstructure. Using homology modeling and binding and contractility assays with recombinant KBTBD13, Kbtbd13-knockout and Kbtbd13R408C-knockin mouse models, and a GFPlabeled Kbtbd13-transgenic zebrafish model, we discovered that KBTBD13 binds to actin - a major constituent of the thin filament - and that mutations in KBTBD13 cause structural changes impairing muscle-relaxation kinetics. We propose that this actin-based impaired relaxation is central to NEM6 pathology.

Consulter en ligne

Suggestions

Du même auteur

Variants in the Oxidoreductase PYROXD1 Cause Early-Onset Myopathy with Internalized Nuclei and Myofibrillar Disorganization

Archive ouverte | O’grady, Gina L. | CCSD

This study establishes PYROXD1 variants as a cause of early-onset myopathy and uses biospecimens and cell lines, yeast, and zebrafish models to elucidate the fundamental role of PYROXD1 in skeletal muscle. Exome sequencing identif...

Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients

Archive ouverte | Vitiello, Libero | CCSD

International audience. Integrative Physiology, a section of the journal Frontiers in Physiology Oxidative stress and mitochondrial dysfunction play a crucial role in the pathophysiology of muscular dystrophies. We ...

PABPN1 nuclear aggregates in oculopharyngeal muscular dystrophy: does age and genotype matters?

Archive ouverte | Roth, Fanny | CCSD

International audience

Chargement des enrichissements...